Stereotactic Radiation and Immunotherapy in Patients With Advanced Triple Negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: RADIATION: SABR|DRUG: Atezolizumab
Sponsor: Peter MacCallum Cancer Centre, Australia
Collaborators: Trans Tasman Radiation Oncology Group